Immunotherapy in patients with melanoma.
D000707:Anaphylaxis / Q000276:immunology; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D001183:Arthus Reaction / Q000276:immunology; D001500:BCG Vaccine; D003168:Complement Fixation Tests; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D005779:Immunodiffusion; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009362:Neoplasm Metastasis; D012882:Skin Tests
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M